Takeda Pharmaceutical Co Ltd

Takeda has established a Climate Action Steering Committee comprised of several workstreams and "meets monthly" to conduct ongoing assessment and monitoring of climate-related issues, including a dedicated "External Advocacy and Engagement" workstream that is "led by our EHS team in partnership with our Global Public Affairs team" and "ensures that our activities that could influence policy are in line with our overall climate strategy." Moreover, Takeda's public position statement on climate change was "produced in partnership with the EHS and Public Affairs team" and "underwent review and approval by the Public Affairs Leadership Team which includes the Public Affairs Heads across all nine business units and global functions to ensure alignment," reflecting a clear pre-approval governance step. Through these mechanisms, the company actively manages its direct engagement with government bodies and its interactions with industry and non-governmental organizations to align lobbying efforts with its climate goals. We found no evidence of a detailed third-party audit or publicly available report evaluating the alignment of its lobbying activities with climate objectives, nor does the company disclose a systematic process for assessing and, if needed, exiting trade associations or alliances whose positions may conflict with its climate policy.